[Phosphodiesterases of cyclic GMP]
- PMID: 11795198
[Phosphodiesterases of cyclic GMP]
Abstract
Phosphodiesterases of cyclic nucleotides (PDEs) are enzymes hydrolyzing cGMP, cAMP or both and are regulated in several different ways. In this paper we summarize current data on structure, cellular and tissue localization, regulation and function of different PDE families that hydrolyze cGMP.
Similar articles
-
Implications of PDE4 structure on inhibitor selectivity across PDE families.Int J Impot Res. 2004 Jun;16 Suppl 1:S24-7. doi: 10.1038/sj.ijir.3901211. Int J Impot Res. 2004. PMID: 15224132 Review.
-
A glutamine switch mechanism for nucleotide selectivity by phosphodiesterases.Mol Cell. 2004 Jul 23;15(2):279-86. doi: 10.1016/j.molcel.2004.07.005. Mol Cell. 2004. PMID: 15260978
-
Cyclic nucleotide phosphodiesterases: relating structure and function.Prog Nucleic Acid Res Mol Biol. 2001;65:1-52. doi: 10.1016/s0079-6603(00)65001-8. Prog Nucleic Acid Res Mol Biol. 2001. PMID: 11008484 Review.
-
Effects of cyclic nucleotide phosphodiesterases (PDEs) on mitochondrial skeletal muscle functions.Cell Mol Life Sci. 2017 May;74(10):1883-1893. doi: 10.1007/s00018-016-2446-0. Epub 2016 Dec 30. Cell Mol Life Sci. 2017. PMID: 28039524 Free PMC article. Review.
-
Diversity in cyclic nucleotide phosphodiesterase isoenzyme families.Arch Biochem Biophys. 1995 Sep 10;322(1):1-13. doi: 10.1006/abbi.1995.1429. Arch Biochem Biophys. 1995. PMID: 7574662 Review. No abstract available.
Cited by
-
Comparative genomic analysis of PIK3R1-mutated and wild-type breast cancers.Breast Cancer Res Treat. 2024 Apr;204(2):407-414. doi: 10.1007/s10549-023-07196-4. Epub 2023 Dec 28. Breast Cancer Res Treat. 2024. PMID: 38153569